Professional Seasonal Analysis for Trading

Praxis Precision Medicines, Inc. - Common Stock (PRAX)

Seasonality Analysis

Stocks 6 Years Analyzed

Praxis Precision Medicines, Inc. - Common Stock Annual Seasonality Statistics

79.41%
Avg Annual Return
51.7%
Avg Monthly Win Rate
7/12
Positive Months
6
Years Analyzed

Praxis Precision Medicines, Inc. - Common Stock Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January 29.28%
50%
Weak
February WORST -16.36%
33%
Very Weak
March -13.80%
33%
Very Weak
April 0.39%
50%
Weak
May -15.06%
20%
Very Weak
June -10.49%
40%
Weak
July 15.42%
60%
Moderate
August 11.02%
40%
Weak
September -1.11%
60%
Weak
October BEST 46.24%
67%
Strong
November 10.56%
83%
Very Strong
December 23.32%
83%
Very Strong

Praxis Precision Medicines, Inc. - Common Stock 2026 vs Historical Pattern

Current Position
89.79
Historical Avg Position
23.92
Deviation
+65.88
Performance
Significantly Above Average

Praxis Precision Medicines, Inc. - Common Stock Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for PRAX with overlay patterns, custom date ranges, and more.

Create Free Account

Praxis Precision Medicines, Inc. - Common Stock Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

Praxis Precision Medicines, Inc. - Common Stock Seasonal Historical Performance

Historical Performance

See historical average returns for PRAX across multiple timeframes.

Create Free Account

About Praxis Precision Medicines, Inc. - Common Stock (PRAX) Seasonality

Praxis Precision Medicines, Inc. - Common Stock (PRAX) has been analyzed using 6 years of historical data to identify seasonal patterns. Classified under Stocks, Praxis Precision Medicines, Inc. - Common Stock shows distinct seasonal tendencies based on historical data.

The strongest month for Praxis Precision Medicines, Inc. - Common Stock is historically October, with an average return of 46.24% and a win rate of 67%. Conversely, February tends to be the weakest month, averaging -16.36% return.

Looking at the full calendar year, Praxis Precision Medicines, Inc. - Common Stock has an average annual return of 79.41% with an overall monthly win rate of 51.7%. Out of 12 months, 7 typically show positive average returns.

The seasonal pattern for Praxis Precision Medicines, Inc. - Common Stock has a consistency score of 49.7 (Poor), based on 7 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

Praxis Precision Medicines, Inc. - Common Stock Seasonality FAQ

What is the best month to buy Praxis Precision Medicines, Inc. - Common Stock (PRAX)?

Historically, October has been the best month for Praxis Precision Medicines, Inc. - Common Stock, with an average return of 46.24% and a win rate of 67%. However, past performance does not guarantee future results.

What is the worst month for Praxis Precision Medicines, Inc. - Common Stock (PRAX)?

Based on historical data, February has been the weakest month for Praxis Precision Medicines, Inc. - Common Stock, with an average return of -16.36%. This is a historical observation and does not guarantee future results.

How reliable is PRAX seasonality data?

The seasonality analysis for Praxis Precision Medicines, Inc. - Common Stock is based on 6 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use Praxis Precision Medicines, Inc. - Common Stock seasonality in my trading?

Use Praxis Precision Medicines, Inc. - Common Stock (PRAX) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.